MTOR and lung carcinoma: For instance, as previously mentioned, TAMs have been shown to regulate the proliferation of KRASG12D mutant lung cancer through mTOR signaling, its reprogramming holds potential for enhancing the therapeutic efficacy in this type of tumor [146].